Cytomx Therapeutics, Inc. · NASDAQ:CTMX

Kynam Capital Management, LP reported a 5.29% stake in Cytomx Therapeutics, Inc. (Schedule 13G)

Event Dec 31, 2025 · Filed Mar 4, 2026

Kynam Capital Management, LP reported a 5.29% stake in Cytomx Therapeutics, Inc., 8,966,077 shares, as a passive investor on Dec 31, 2025. Filed Mar 4, 2026 (Schedule 13G).

Stake
5.29%
Shares
8,966,077
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Kynam Capital Management, LP5.29%8,966,077
Kynam Capital Management GP, LLC5.29%8,966,077
Yue Tang5.29%8,966,077

Source

View original at SEC

Related